CA
NZ
UK
AU
IND
US
Key HighlightsAlphabet (NASDAQ:GOOGL) introduced two new tensor processing unit systems on November 9, 2026: the TPU 8tx for confidential AI work and the TPU 8i Max for very long context inference.The TPU 8tx pairs Google's accelerator silicon with fifth-generation AMD EPYC host processors, and …
The filing mentions a potential sale of the Digital business, with milestones tied to the Thirteenth Amendment of theCreditagreement and lender consent required for any sale. NoMergeror take-private is disclosed and no guidance appears in the filing. General context: a narrower loss, a deleveraging …
Key HighlightsHims & Hers Health (NYSE:HIMS) closed at USD 22.98 on November 9, 2026, down 11.77% from USD 26.00 ahead of its after-close report, then touched USD 20.63 in extended trading.Third-quarterRevenuerose 49% to USD 890.4 million, in line with guidance of USD 880 million …
Background from earlier 2026 coverage: the company announced a merger with BlockFuel Energy on February 12, 2026, aimed at an energy and digital infrastructure platform, with one published summary valuing the transaction between USD 220 million and USD 343 million and mentioning a restart …
Key HighlightsChairs of three House committees wrote to Nvidia (NASDAQ:NVDA) chief executive Jensen Huang on November 9, 2026, asking him to attend a joint, closed-door briefing on November 18.The letter seeks information on the company's "security protocols against foreign adversary espionage" and Huang's interactions …
No company release or filing dated November 9 or November 10, 2026 was found in published coverage, so no catalyst is identified. The most recent company items were the August 31, 2026 pricing of an oversubscribed USD 50 million public offering, a 42 million …
The bounce does not resolve the open questions. The review has no published end date, and its findings could still lead toLeadershipchanges. Nvidia has no clear succession plan, which makes key person risk unusually high for a company of its size. House committees have …
No company release or filing dated November 9 or November 10, 2026 was found, so no catalyst is identified. The recent record is a series of listing and structure items. ANasdaqminimum bid price deficiency notice came on June 18, 2026. Further Nasdaq notices on …
IVV tracks the S&P 500, so its next move depends on whether CPI confirms the relief rally. A soft core reading of 0.2% or lower would support lower Treasury yields and could extend gains in rate-sensitive sectors. A hot reading would raise the odds …
Key HighlightsIambic Therapeutics (NASDAQ:IAM) was quoted at USD 14.81 pre-market on Tuesday, November 10, 2026, up 10.69% from a calculated prior close of USD 13.38 set in the November 9 session.The stock priced its IPO at USD 16.00 on October 15, 2026, selling 9.375 …
Please wait processing your request...